Your browser version may not work well with NCBI's Web applications. More information here...
1: PLoS Pathog. 2005 Dec;1(4):e35. Epub 2005 Dec 2.
Related Articles, Links
Click here to read Click here to read Click here to read
A novel endogenous inhibitor of the secreted streptococcal NAD-glycohydrolase.

Meehl MA, Pinkner JS, Anderson PJ, Hultgren SJ, Caparon MG.

Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.

The Streptococcus pyogenes NAD-glycohydrolase (SPN) is a toxic enzyme that is introduced into infected host cells by the cytolysin-mediated translocation pathway. However, how S. pyogenes protects itself from the self-toxicity of SPN had been unknown. In this report, we describe immunity factor for SPN (IFS), a novel endogenous inhibitor that is essential for SPN expression. A small protein of 161 amino acids, IFS is localized in the bacterial cytoplasmic compartment. IFS forms a stable complex with SPN at a 1:1 molar ratio and inhibits SPN's NAD-glycohydrolase activity by acting as a competitive inhibitor of its beta-NAD+ substrate. Mutational studies revealed that the gene for IFS is essential for viability in those S. pyogenes strains that express an NAD-glycohydrolase activity. However, numerous strains contain a truncated allele of ifs that is linked to an NAD-glycohydrolase-deficient variant allele of spn. Of practical concern, IFS allowed the normally toxic SPN to be produced in the heterologous host Escherichia coli to facilitate its purification. To our knowledge, IFS is the first molecularly characterized endogenous inhibitor of a bacterial beta-NAD(+)-consuming toxin and may contribute protective functions in the streptococci to afford SPN-mediated pathogenesis.

Publication Types:
PMID: 16333395 [PubMed - indexed for MEDLINE]

PMCID: PMC1298937